Evidence map›Paper›PMID 23993098›Full record

ArticleCell2013

The CRTC1-SIK1 pathway regulates entrainment of the circadian clock.

Aarti Jagannath, Rachel Butler, Sofia I H Godinho, Yvonne Couch, Laurence A Brown, Sridhar R Vasudevan, Kevin C Flanagan, Daniel Anthony, Grant C Churchill, Matthew J A Wood and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Regulation of Sleep Amount by CRTC1 via Transcription ofThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Aarti JagannathNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; pRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Rachel ButlerNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; pRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Sofia I H GodinhoNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; pRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Yvonne CouchDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
Laurence A BrownNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.
Sridhar R VasudevanDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
Kevin C FlanaganDepartment of Biological Sciences, University of Notre Dame, Galvin Life Sciences Center, Notre Dame, IN 46556, USA.
Daniel AnthonyDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
Grant C ChurchillDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
Matthew J A WoodDepartment of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK.
Guido SteinerpRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Martin EbelingpRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Markus HossbachAxolabs GmbH Fritz-Hornschuch-Straße 9, 95326 Kulmbach, Germany.
Joseph G WettsteinpRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Giles E DuffieldDepartment of Biological Sciences, University of Notre Dame, Galvin Life Sciences Center, Notre Dame, IN 46556, USA.
Silvia GattipRED Pharma Research and Development F. Hoffmann-La Roche, 4070 Basel, Switzerland.
Mark W HankinsNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.
Russell G FosterNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK. Electronic address: russell.foster@eye.ox.ac.uk.
Stuart N PeirsonNuffield Department of Clinical Neurosciences (Nuffield Laboratory of Ophthalmology), University of Oxford, Levels 5-6 West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK. Electronic address: stuart.peirson@eye.ox.ac.uk.
University of Oxford · GBRoche (Switzerland) · CHJohn Radcliffe Hospital · GBUniversity of Notre Dame · US

Funding

Function of Inhibitor of DNA binding (id) genes in the circadian systemR01GM087508 · NIGMS · UNIVERSITY OF NOTRE DAME · PI DUFFIELD, GILES · 2010 to 2014
$1.4M
Biotechnology and Biological Sciences Research Council BB/G008523/1Medical Research Council G0900887NIGMS NIH HHS R01 GM087508Parkinson's UK G-0503Parkinson's UK G-1109Wellcome TrustWellcome Trust 090684/Z/09/ZWellcome Trust R01-GM087508
6 · The paper itself

Abstract

Retinal photoreceptors entrain the circadian system to the solar day. This photic resetting involves cAMP response element binding protein (CREB)-mediated upregulation of Per genes within individual cells of the suprachiasmatic nuclei (SCN). Our detailed understanding of this pathway is poor, and it remains unclear why entrainment to a new time zone takes several days. By analyzing the light-regulated transcriptome of the SCN, we have identified a key role for salt inducible kinase 1 (SIK1) and CREB-regulated transcription coactivator 1 (CRTC1) in clock re-setting. An entrainment stimulus causes CRTC1 to coactivate CREB, inducing the expression of Per1 and Sik1. SIK1 then inhibits further shifts of the clock by phosphorylation and deactivation of CRTC1. Knockdown of Sik1 within the SCN results in increased behavioral phase shifts and rapid re-entrainment following experimental jet lag. Thus SIK1 provides negative feedback, acting to suppress the effects of light on the clock. This pathway provides a potential target for the regulation of circadian rhythms.

Indexed as

Circadian ClocksSignal TransductionActive Transport, Cell NucleusAnimalsCircadian RhythmCyclic AMP Response Element-Binding ProteinGene Knockdown TechniquesMelanopsinMiceMice, Inbred C57BLProtein Serine-Threonine KinasesRNA, Small InterferingRod OpsinsSuprachiasmatic NucleusTranscription FactorsTranscription, GeneticCrtc1 protein, mouseCyclic AMP Response Element-Binding ProteinMelanopsinProtein Serine-Threonine KinasesRNA, Small InterferingRod OpsinsSik1 protein, mouseTranscription Factors

Identifiers

PMID23993098
PMCPMC3898689
OpenAlexW2156902902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.